Additional information
Grey colour Powder
191939-34-1
ACI-021717
–
C16H20ClN3O2S • HCl
390.33
Ambient
2-8°C
Chemotherapy
Pharmaceutical Impurity Standards
4-(6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4',5':5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanoic Acid Hydrochloride
4-(6-(2-Chloroethyl)-3-methyl-3,6,7,8-tetrahydroimidazo[4',5':5,6]benzo[1,2-b][1,4]thiazin-2-yl)butanoic Acid Hydrochloride
Imidazo[4,5-h][1,4]benzothiazine-2-butanoic acid, 6-(2-chloroethyl)-3,6,7,8-tetrahydro-3-methyl





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)